Proteome dynamics of COVID-19 severity learnt by a graph convolutional network of multi-scale topology
Abstract
Many efforts have been recently done to characterise the molecular mechanisms of COVID-19 disease. These efforts resulted in a full structural identification of ACE2 as principal receptor of the Sars-CoV-2 spike protein in the cell. However, there are still important open questions related to other proteins involved in the progression of the disease. To this end, we have modelled the plasma proteome of 384 COVID patients. The model calibrated proteins measures at three time tags and make also use of the detailed clinical evaluation outcome of each patient after their hospital stay at day 28. Our analysis is able to discriminate severity of the disease by means of a metric based on available WHO scores of disease progression. Then, we identify by topological vectorisation those proteins shifting the most in their expression depending on that severity classification. Finally, the extracted topological invariants respect the protein expression at different times were used as base of a graph convolutional network. This model enabled the dynamical learning of the molecular interactions produced between the identified proteins.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
D. Feyaerts, J. Hedou, … D. R. McIlwain·bioRxiv·Feb 9, 2021
- In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients
Joonho Park, Hyeyoon Kim, … Dohyun Han·Scientific ReportsPeer-reviewed·Dec 29, 2020
- Proteomic profiling identifies biomarkers of COVID-19 severity
Noa C. Harriott, Amy L. Ryan·HeliyonPeer-reviewed·Dec 4, 2023
- Time-based quantitative proteomic and phosphoproteomic analysis of A549-ACE2 cells during SARS-CoV-2 infection
Fátima Milhano dos Santos, Jorge Vindel-Alfageme, … Fernando José Corrales·Journal of Proteome ResearchPeer-reviewed·Nov 27, 2024
- Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients
Michael R. Filbin, Arnav Mehta, … Marcia B. Goldberg·Cell Reports MedicinePeer-reviewed·May 1, 2021
- COVIDpro: Database for mining protein dysregulation in patients with COVID-19
Fangfei Zhang, Augustin Luna, … Tiannan Guo·Journal of Proteome ResearchPeer-reviewed·Aug 9, 2023